The endogenous cannabinoid, anandamide (arachidonoylethanolamide), and the sleep-inducing factor, oleamide (cis-9-octadecenoamide), represent two classes of long-chain fatty acid amides with several neuronal actions and metabolic pathways in common. Here we report that these two compounds are present in human breast carcinoma EFM-19 cells and rat adrenal pheochromocytoma PC-12 cells, together with the enzyme responsible for their degradation, fatty acid amide hydrolase, and the proposed biosynthetic precursors for arachidonoylethanolamide and related acylethanolamides, the N-acyl-phosphatidylethanolamines. Lipids extracted from cells labelled with [
oughly (for reviews see [4Ϫ7] ). Another long-chain ethanolam-duction and inactivation of these compounds influenced by cell differentiation into sympathetic-like neurons ? Are these metaboide, palmitoylethanolamide (PEA), which cannot be considered an anandamide since it does not bind CB1 receptors, was known lites synthesised and degraded by human breast cancer cells, where a strong and selective anti-proliferative action by AEA from previous studies to behave as a possible anti-inflammatory agent (reviewed in [8] ). More recently, PEA was shown to in-has been recently discovered [34] ? Is oleamide present also in peripheral cells, and does it function as an endogenous enhancer hibit serotonin release from mast cells [9] , as well as mast cellmediated hyperreactivity [10] , and to prevent glutamate-induced of AEA actions also in these cells? Therefore, we examined the occurrence of AEA, PEA, the corresponding acyl-PtdEtns, and excitotoxicity in cerebellar granule cells [11] . Both these actions were suggested to be mediated by non-CB1 cannabinoid recep-oleamide, as well as the expression of AEA amidohydrolase/ fatty acid amide hydrolase, in : (a) rat adrenal pheochromocytors, possibly of the peripheral (CB2) subtype [9, 11] . AEA and PEA, together with other acylethanolamides, were found : (a) to toma PC-12 cells, either naive or differentiated into neuron-like cells by a two-week treatment with the nerve growth factor be co-produced upon ionomycin stimulation of several cell types, e.g. rat cortical and striatal neurons [12] , rat basophilic (NGF), and (b) human breast cancer EFM-19 cells, and studied the anti-proliferative effect of oleamide in these latter cells. leukaemia (RBL-2H3) cells and mouse J774 macrophages [13, 14] , probably through the phospholipase-D-catalysed hydrolysis of the corresponding N-acyl-phosphatidylethanolamines (acylPtdEtns) [8] ; (b) to co-exist, together with the acyl-PtdEtns, in MATERIALS AND METHODS all mammalian and invertebrate tissues examined so far (for example see [15Ϫ20]), and (c) to be recognised, in N18TG2, RBLCell culturing. EFM-19, RBL-1, J774 and N18TG2 cells were purchased from Deutsche Sammlung von Mikroorganismen 2H3 and RBL-1 cells, by the same hydrolytic enzyme, AEA amidohydrolase, albeit with significantly different affinities [14] . and cultured according to the intructions of the manufacturer.
PC-12 cells were donated by Dr A. Leon (Research & Innova-AEA amidohydrolase displays an alkaline optimal pH, and is localised on microsomal and mitochondrial membranes from tion, Vicenza) and grown in 85% RPMI 1640, 15% horse serum and 5% foetal calf serum in the presence of 25 U/ml penicillin, several mammalian tissues, including brain, liver and kidney [20Ϫ23] . Due to these properties, this enzyme is likely to be the 25 µg/ml streptomycin and 2 mM glutamine. PC-12 cells, seeded on petri dishes treated with 200 µg/dish collagen S same amidase previously shown to catalyse the hydrolysis of saturated and monounsaturated fatty acid ethanolamides [24] . (Boehringer Mannheim), were differentiated into neuron-like cells (as indicated by the formation of a net of neurites upon Moreover, AEA amidohydrolase has been suggested to be identical to fatty acid amide hydrolase, the enzyme catalysing oleam-observation under an inverted light microscope) by daily treatment with 50 ng/ml mouse NGF 7 S (Alomone Labs) for two ide hydrolysis, which was cloned from rat liver [25], over-expressed by transfection into host cells, and found to recognise weeks. Undifferentiated PC-12 cells were grown on collagentreated dishes as a control for differentiated cells. AEA as the preferential substrate as well as other fatty acid primary amides and methyl esters [25, 26] . Evidence that AEA Extraction, purification, characterisation and quantitation of AE, PEA, oleamide and acyl-PtdEtns. AEA, PEA and and oleamide are substrates for the same hydrolytic enzyme had already been gained in previous studies conducted in N18TG2 oleamide were synthesised in large amounts and purified as previously described [2, 3] . Lipids, from cells either unlabelled or cells [27] , and was provided also for the recently cloned mouse and human fatty acid amide hydrolase [28] . However, the exis-labelled by overnight treatment with 0.1 µCi/ml [ 14 C]ethanolamine (52 mCi/mmol, Amersham) or [ 3 H]arachidonic acid tence of other amidohydrolases selective for either AEA or oleamide has not been ruled out [25] , even though a recent study, (230 Ci/mmol, NEN), were extracted and purified by a sequence of chromatographic steps described previously [13, 14, 35] and by showing that rat tissues contain amounts of AEA amidohydrolase comparable to their fatty acid amide hydrolase mRNA including open chromatography on silica gel, TLC, normalphase and reverse-phase HPLC. In some experiments cells were levels, provided further evidence that these two are the same enzyme [29] . No data are available on the possible regulation of stimulated with 5 µM ionomycin (Sigma) for 30 min at 37°C prior to lipid extraction [14] . Briefly, chloroform/methanol (2 :1, fatty acid amide hydrolase during cell differentiation into neurons.
by vol.) extracts of cells were loaded onto silica gel columns. Two fractions, eluted with chloroform/methanol (9 :1, by vol. Apart from inducing sedation in rats, oleamide was also shown to mimick AEA by inhibiting lymphocyte proliferation and 1:1, by vol.), were purified by normal phase-HPLC with nhexane/2-propanol as described previously [13, 14] , and TLC [30] and exhibiting a weak but significant activity in the tetrad of mouse behavioural tests (hypothermia, antinociception, inhi-developed with chloroform/methanol/NH 4 OH (85:15:1, by vol.)
respectively. The NAPE-like components were scraped from bition of locomotor activity), which are highly indicative of cannabinoid compounds [31] . However, oleamide does not bind to TLC plates and digested with Streptomyces chromofuscus phospholipase D as described [13, 14] . The digests were purified by either cannabinoid receptor subtype [31] . Due to the fact that oleamide can serve as a substrate for the same enzyme catalys-normal-phase HPLC and fractions with the same retention time (27Ϫ28 min) as acylethanolamide standards, from either the 9 :1 ing the hydrolysis of AEA [25Ϫ28], it was hypothesised that some of the pharmacological actions of oleamide, including silica column fractions or the digestion of acyl-PtdEtns-like lipids, were purified further by reverse-phase HPLC with methasleep induction, were due to an enhancement of endogenous AEA levels [31] . Accordingly, oleamide, which is present in nol/water as described previously [13, 14] , under conditions allowing the separation between different acylethanolamides. Ex-N18TG2 cells in amounts up to 100 times higher than AEA [32], was found to inhibit AEA degradation by both cell-free and periments aiming at the full characterisation of AEA, PEA, oleamide and acyl-PtdEtns were carried out with unlabelled conwhole cell preparations and to potentiate AEA effects in the tetrad of tests [31] . However, due to the lack of efficacy of the fluent cells scraped from ten 100-mm petri dishes (approximately 10 8 cells). The normal-phase HPLC fractions with the only selective CB1 receptor antagonist developed to date, SR 141716A [33] , against AEA actions in these in vivo tests in mice same retention time as acylethanolamide and oleamide (26 min) standards were submitted to gas chromatography/electron-im-[42], it was not possible to confirm this hypothesis conclusively.
In the present study we have addressed three open questions pact mass spectrometry (GC/EIMS) as described previously [14] , using, alternatively, an isotope dilution methodology for concerned with bioactive fatty acid amide research. Is the pro-the quantitation of acetoxy-AEA in the selected-ion monitoring fluent cells (at a density of about 50 000 cells/well) [34] . Substances to be tested were introduced 24 h after cell seeding and mode, or the full mass spectra acquisition mode for structure determination of other acetoxy-acylethanolamides and character-then daily with each change of medium. Various doses of the substances were assayed and cells trypsinised and counted at isation and quantitation of underivatised oleamide [32] . In the former case, measurements of AEA in the 0.05Ϫ10-mol range confluence after 6 days by a hemocytometer. This also allowed cell viability to be checked by the addition of trypan blue to in mixture with 1 nmol of [ 2 H 8 ]AEA are possible [14] , while in the latter case, standard curves for oleamide were constructed aliquots of trypsinised cells. No significant decrease in cell viability was observed with up to 100 µM AEA, PEA or oleamide. with 0.1Ϫ5 nmols of the synthetic compound which ran immediately after the unknown samples [32] .
In separate sets of experiments, various doses of AEA were tested in the presence of 0.5 µM oleamide, and 10 µM oleamide Inactivation of AEA by intact EFM-19 and PC-12 cells. Experiments were carried out with intact confluent cells in either was tested in the presence of the CB1 antagonist, SR 141716A (0.5 µM), which was kindly donated by Sanofi Recherche. Sta-100-mm collagen-treated petri dishes (as in the case of PC-12 cells) or 6-well dishes (as in the case of EFM-19 cells). In the tistically significant differences between different treatments were evaluated by using the unpaired Student's t-test with former case, cells were washed three times with 5 ml serum-free medium and then incubated with [
14 C]AEA (5 Ci/mol), prepared P Ͻ 0.05 as the threshold for significance. from [
14 C]ethanolamine and arachidonic acid as described [35] , and diluted to 50 µM (10 000 cpm/ml in 6 ml). 500-µl aliquots were then taken after various intervals of time and [
14 C]ethanolamine produced from [
14 C]AEA hydrolysis measured as de-RESULTS scribed previously [14] . In the second case, cells, after three
Occurrence of AEA, PEA, oleamide and acyl-PtdEtns in washes with 1 ml serum-free medium, were incubated with EFM-19 cells. When EFM-19 cells were labelled overnight with [
14 C]AEA (10 000 cpm/ml in 1 ml) for increasing periods of 14 C]AEA retained ethanolamide in both normal-phase and reverse-phase HPLC by cells after three washes with 2 ml medium containing 1 % were found in the silica column fraction eluted with chloroform/ BSA, were measured as described previously [14] . methanol (9 :1, by vol.) (Fig. 1A) . (Fig. 1 B) . droxy-mercuribenzoate (p-HMB, 100 µM, Sigma), EDTA Conclusive evidence for the presence of AEA, PEA and (5 mM), arachidonoyltrifluoromethane (∆4AchCOMeF3, 50 µM), stearoylethanolamide, as well as of the corresponding acylarachidonoyldiazomethane (∆ 4 AchCOCHN 2 , 50 µM), arachidoPtdEtns, in these cells was obtained by GC/EIMS analysis (data noylchloromethane (∆ 4 AchCOCH 2 Cl, 50 µM) and methylnot shown) of the acetylated normal-phase HPLC peaks with the arachidonoyl fluorophosphonate (Me∆4AchPOF, 50 nM, Bioretention time of synthetic AEA from both the 9:1 silica column mol, UK), or of oleamide and PEA (100 µM). ∆ 4 AchCOMeF 3 , fraction and the digestion of the acyl-PtdEtns-like TLC fraction. ∆ 4 AchCOCHN 2 and ∆ 4 AchCOCH 2 Cl were synthesised as deThe 9:1 fraction also contained a GC peak with a EIMS fragscribed previously [36, 37] . mentation pattern undistinguishable from that of synthetic Northern blot analyses. A cDNA fragment for rat fatty acid oleamide (data not shown). EIMS spectra and fragmentation patamide hydrolase was prepared by reverse transcriptase/polymerterns of underivatised synthetic oleamide and of the acetoxyase chain reaction using rat liver poly(A)-rich RNA as a temderivatives of both synthetic and natural AEA, PEA, and plate. The primers used were an upstream primer 5′-stearoylethanolamide have been published previously [14, 19, GCCTGAAAGCTCTACTGTGTGAGC-3′ and a down-stream 32]. Oleamide levels were 160 Ϯ40 pmol/10 7 cells (mean primer 5′-GCTCTAGATTACGATGGCTGCTTTTGAGG-3′. ϮSEM, n ϭ 3). The amounts of AEA in the 9:1 fraction were The cDNA fragment was then digested with XbaI resulting in below the level measurable with the isotope dilution procedure the formation of a 781-bp fragment containing 1014Ϫ1787 (as used here (50 pmol), although well above the detection limit from [25] ). The latter fragment was labelled with [A-32 P]dCTP (5 pmol). Experiments carried out with cells labelled with by the random primer DNA labelling system. Total RNA was [ 14 C]ethanolamine and treated with 5 µM ionomycin showed extracted from rat liver and EFM-19, PC-12, RBL-1, J774 and that the levels of the endogenous radioactive acylethanolamides N18TG2 cells using a mixture of guanidium isothiocyanate and and acyl-PtdEtns were not sensitive to ionomycin stimulation phenol (Isogen, Nippon Gene). The RNA (25 µg) was denatured, (Fig. 1 C) . subjected to electrophoresis on a 1 % agarose formaldehyde gel, transferred to a Hybond-N ϩ membrane and hybridised with the ( Fig. 1 D and data not shown) . When submitted to digestion with ide significantly inhibited [
14 C]AEA hydrolysis by both EFM-S. chromofuscus phospholipase D, the acyl-PtdEtns-like TLC 19 (Fig. 2 B) and PC-12 (data not shown) intact cells, thus leadfraction yielded a lipid with the same retention time as synthetic ing to a corresponding increase of [
14 C]AEA in the incubation acylethanolamides in normal-phase HPLC fractions (Fig. 1E) . medium. Oleamide did not significantly affect [
14 C]AEA uptake The levels of the acylethanolamides and acyl-PtdEtns-like com-by EFM-19 cells (Fig. 2 B) . Cell-free homogenates from both pounds were not significantly altered upon cell differentiation cell types contained an enzymatic activity capable of catalysing into neuron-like cells, nor on cell stimulation with 5 µM iono-[
14 C]AEA hydrolysis. This was mostly found associated with mycin (Fig. 1 F) . The AEA-like HPLC fractions, from either the particulate fractions (10 000ϫg mitochondrial and 100 000ϫg 9:1 column fractions or the digested acyl-PtdEtns-like TLC microsomal fractions) (Table 1), as previously described for fractions, were acetylated and submitted to GC/EIMS analyses other AEA amidohydrolase activities [14, 19, 21Ϫ29] . Morewhich showed the presence of very little, albeit clearly detect-over, the amidohydrolase activity displayed apparent active-site able, amounts of compounds with retention times and frag-pK a values at around 5.5Ϫ6.0 and 9.5Ϫ10.0 (Fig. 2 C) , similar mentation patterns identical to those of AEA, PEA and to those previously observed both with AEA amidohydrolase stearoylethanolamide standards (data not shown); oleamide was enzymes and fatty acid amide hydrolase [14, 19, 22, 25, 27, 28] . present also in this case, in amounts much higher than AEA and The enzymatic hydrolysis of [
14 C]AEA was also significantly PEA and not sensitive to NGF treatment (683Ϯ 166 pmol/10 7 counteracted by typical inhibitors of these enzymes [36, 37], as cells, meanϮSEM, n ϭ 3). The levels of AEA in the 9:1 frac-well as by 100 µM oleamide but not by 100 µM PEA (Table 2) . tion from both naive and differentiated PC-12 cells were below In EFM-19 cells, apparent K m and Vmax values for [ 14 C]AEA the level measurable with the isotope dilution procedure used hydrolysis were, 12.8Ϯ8.0 µM and 0.79Ϯ0.30 nmol min Ϫ1 mg here (50 pmol) and just above the detection limit (5 pmol). protein Ϫ1 respectively, (meansϮSEM, n ϭ 3) (Fig. 2 D) . (Fig. 2A, B) . The rate of protein Ϫ1 in transformed cells; means Ϯ SEM, n ϭ 3) of the en-[
14 C]AEA hydrolysis was not significantly changed by PC-12 differentiation into neuron-like cells (Fig. 2 A) . 100 µM oleam-zyme (Fig. 2 C, D, Tables 1, 2) . and, therefore, the activities found were lower than the calculated Vmax described to contain an AEA amidohydrolase activity [14, 27] . values PC-12 cells were grown on collagen-treated petri dishes and Accordingly, bands with the same mobility as rat FAAH mRNA either left untransformed or differentiated into cells with neuronal phenowere detected in RNA preparations from rat PC-12 and RBL-1 type by two-week treatment with 50 ng/ml NGF. cells (Fig. 3) either undifferentiated or differentiated PC-12 cells (Fig. 3) .
Microsomes (100 000ϫ g) 9.8 Ϯ 0. Oleamide, which had not been tested before, also exerted a significative cytostatic action, although at ferentiated PC-12 cells, and RBL-1, N18TG2 and J774 cells, were submitted to agarose gel electrophoresis and northern blot higher concentrations than AEA (estimated IC 50 ϭ 11.3 µM, . Finally, we (0.5 µM), significantly potentiated AEA anti-proliferative action wanted to find out whether oleamide, previously shown to exert (estimated IC 50 ϭ 1.2 µM, Fig. 4 B) , whereas the selective CB1 some cannabimimetic properties [30, 31] , shared with AEA also antagonist SR 141716A (0.5 µM) [33] fully antagonized the the cytostatic action on breast cancer cells and, if so, through anti-proliferative action of both AEA [34] and 10 µM (Fig. 4A) what mechanism. In the attempt to achieve these three tasks, we oleamide.
have provided evidence for the presence of AEA and PEA in gland-derived peripheral cell types, as well as unprecedented data on the presence of oleamide outside the nervous system. In DISCUSSION both EFM-19 and PC-12 cells, AEA and PEA were accompanied by higher levels of their putative biosynthetic precursors, In this study, starting from the lack of data on the effect of cell differentiation on acylethanolamide metabolism, we wanted the corresponding acyl-PtdEtns. The biosynthesis of AEA and PEA in EFM-19 and PC-12 cells, unlike that in rat central neuto assess whether the biosynthesis and degradation of AEA, PEA and congeners in PC-12 cells are subject to regulation following rons and murine tumoral leukocytes [12Ϫ14], was not induced by ionomycin stimulation (Fig. 1) . This may be due to low sensi-NGF stimulation and subsequent transformation into cells with a phenotype typical of sympathetic neurons. Next, we wanted to tivity of cells to ionomycin, as previously observed for undifferentiated neuroblastomaϫglioma NG 108ϫ15 hybrid cells investigate whether human breast cancer cells, where AEA exerts a potent anti-proliferative action [34] , have the means to [13, 35] , or to the occurrence of biochemical pathways for acylethanolamide formation that are not dependent on extracelbiosynthesise and inactivate this compound, and, therefore, to assess whether the function of autacoid suppressor of mammary lular calcium, as recently suggested for another endocrine gland, rat testis [38] . Our data, however, do not rule out the possibility (Fig. 2 B) . This was to be expected from the fact that FAAH/ AEA amidohydrolase recognises as substrates both AEA and that acylethanolamide biosynthesis in EFM-19 and PC-12 cells may be induced by stimuli causing the mobilisation of calcium oleamide, and is therefore inhibited by oleamide when using [ 14 C]AEA as a substrate (Table 2) . A similar phenomenon was from intracellular stores. More importantly, we found that the levels of acylethanolamides and the corresponding acyl-PtdEtns recently described also for N18TG2 cells, and was suggested to be at the basis of the weak cannabimimetic activity exerted by did not vary following NGF-induced PC-12 cell transformation into sympathetic-like neurons (Fig. 1) . This indicates that the oleamide, and of the facilitatory action of the latter compound on AEA action, in the tetrad of mouse behavioural tests [31] . enzymes so far suggested to be involved in acylethanolamide generation are not subject to up-regulation following prolonged We have previously shown that AEA, by acting at CB1-like receptors, can potently inhibit EFM-19 cell proliferation [34] . NGF treatment of PC-12 cells. According to the two biosynthetic pathways proposed so far for the acylethanolamides, these Here, we wanted to see whether oleamide, which does not bind to CB1 receptors but affects AEA levels at these receptors and enzymes are: (a) a calcium-dependent trans-acylase catalysing the biosynthesis of acyl-PtdEtns through the transfer of acyl shares with AEA several pharmacological actions [30, 31] , would exhibit a similar cytostatic action. We found that oleammoieties from the sn-1 position of phospholipids to the N-position of phosphatidylethanolamine and an acyl-PtdEtn-selective ide can exert an anti-proliferative action on EFM-19 cells at fivefold higher concentrations than AEA (Fig. 4A) and that a phospholipase D [8, 12, 39] , or (b) a synthase catalysing the energy-free condensation of fatty acids and ethanolamine [8, 22 , low, ineffective, concentration of the primary amide could significantly potentiate AEA anti-proliferative effect (Fig. 4 B) . 39Ϫ41]. Our data may also suggest that sympathetic neurons may differ from central neurons by their capability of producing PEA, which does not significantly inhibit the enzymatic hydrolysis of [ 14 C]AEA by cell particulate fractions (Table 2) , was AEA. This suggestion may be relevant to the recent finding that macrophage-derived (and not necessarily sympathetic-neuron-inactive (data not shown). These findings may indicate, as suggested previously for some of its in vivo effects [31] , that oleamderived) anandamide may be responsible for hypotension in haemorrhaged or endotoxin-stimulated rats [43, 44] . Also the ide, at high concentrations such as those present in EFM- 19 cells, but not PEA, might inhibit cell proliferation through raised amounts of oleamide, whose biosynthetic pathway in the central nervous system has not yet been clarified [32], did not change levels of endogenous AEA, whose hydrolysis is minimised by the primary amide, but not by the saturated acylethanolamide. upon PC-12 cell differentiation. As previously observed for N18TG2 cells [32] , oleamide levels in both EFM-19 and PC-12 Accordingly, the CB1 antagonist SR 141716A (which inhibits AEA antiproliferative effect in EFM-19 cells [34]), blocked cells, as measured by GC/MS, were much higher than the amounts estimated for AEA. The latter were below the lower oleamide cytostatic action (Fig. 4A) , suggesting that the latter is mediated by an endogenous cannabinoid substance, possibly limit of measurement (50 pmol, 5 pmolϫ10 7 cells) and above the upper detection limit (5 pmol, 0.5 pmolϫ10 7 cells) of the AEA.
In conclusion, in this study we have shown that the sleep-GC/MS method used here, and therefore comparable to those measured by GC/MS in rat and human brain [15] (10 7 cells cor-inducing factor oleamide is present in non-nervous tumoral cell lines and that the levels of acylethanolamides, acyl-PtdEtns and respond to about 0.1 g wet tissue). As to the low levels of AEA in adrenal PC-12 cells, it is worthwhile noting that comparable oleamide, on the one hand, and of FAAH, on the other hand, do not vary upon NGF-induced differentiation of one such cell line amounts (about 8 pmol/g wet tissue) of this compound have been recently described in rat kidney and mesangial cells [20] .
(PC-12 cells) into sympathetic neuron-like cells. In EFM-19 cells, where we have shown here that oleamide, like AEA, inhibAn AEA amidohydrolase activity, identified on the basis of its typical subcellular distribution, pH dependency profile and its cell proliferation, the presence of AEA, its putative precursor N-arachidonoyl-PtdEtn, oleamide and the enzyme FAAH, indisensitivity to inhibitors, was also found in both PC-12 and EFM-19 cells (Fig. 2, Tables 1 and 2 ). RNA transcripts for FAAH, the cate that these cells have the means to synthesize and inactivate both bioactive fatty acid amides. This, in turn, suggests that enzyme catalysing the hydrolysis of both long-chain fatty acid ethanolamides and primary amides [25, 28] , were also detected oleamide and AEA may function as autocrine, protective signals for the down-regulation of human breast cancer cell proliferain EFM-19 and PC-12 cells, as well as in two other cell lines previously described to express AEA amidohydrolase activity, tion. A general function for oleamide as an enhancer of AEA action through substrate competition for FAAH, and subsequent i.e. N18TG2 and RBL-1 cells, but were not present in J774 cells, which contain only negligible amounts of this activity [14, 27] increase of AEA endogenous levels, seems to conclusively emerge from the data presented here. Moreover, the observation (Fig. 3) . The amounts of AEA amidohydrolase in either untransformed or transformed PC-12 cells were approximately the same that the anti-proliferative action of AEA is potentiated by oleamide may be of considerable pharmacological importance if and so were the intensities of the bands of the FAAH transcripts in northern blot analyses of RNA from both types of cells. These shown to occur also in vivo. Future experiments will need to address further the issue of the regulation of the enzymes infindings indicate that the expression of this protein is not altered following NGF-induced transformation of PC-12 cells, which, volved in AEA, PEA and oleamide metabolism in both central and peripheral tissues. moreover, did not modify the enzyme subcellular distribution, pH dependency profile and sensitivity to inhibitors, nor its affin-
